![BIGBEAR Pharmaceutical объявляет об одобрении биниметиниба[Binimetinib] и энкорафениба[Encorafenib] в Лаосе](https://lienteh.net/wp-content/uploads/2024/10/2024-10-1274-150x150.webp "BIGBEAR Pharmaceutical объявляет об одобрении биниметиниба[Binimetinib] и энкорафениба[Encorafenib] в Лаосе")
Vientiane, Laos - October 12 2024 - BigBear Pharma, a leading biopharmaceutical company focused on developing and commercializing innovative cancer treatments, today announced that Binimetinib…
Read More
Vientiane, Laos - September 20, 2024 - BigBear Pharma, a leading biopharmaceutical company focused on developing and commercializing innovative cancer treatments, today announced that…
Read More
Вьентьян, Лаос - 12 октября 2024 г. - BigBear Pharma, ведущая биофармацевтическая компания, занимающаяся разработкой и коммерциализацией инновационных методов лечения рака, сегодня объявила, что…
Read MoreIntroduction If you are looking for new business opportunities in the pharmaceutical industry, there is a product for you: Generic Mitotane sold under the brand…
Read More
Вьентьян, Лаос – 8 апреля 2024 г. – BigBear Pharma, ведущая биофармацевтическая компания, занимающаяся разработкой и коммерциализацией инновационных методов лечения рака, сегодня объявила, что…
Read More
О препарате Aumolertinib Aumolertinib (ранее известный как almonertinib) — это ингибитор тирозинкиназы EGFR, нацеленный на сенсибилизирующие мутации EGFR…
Acerca de Aumolertinib Aumolertinib (anteriormente conocido como almonertinib) es un inhibidor de la tirosina quinasa del EGFR que…
About Capivasertib Capivasertib is an orally bioavailable, small-molecule inhibitor of all three AKT isoforms. Capivasertib used…
About Ritlecitinib Ritlecitinib is a kinase inhibitor which inhibits Janus kinase 3 and tyrosine kinase. Ritlecitinib…
Lazertinib is a potent irreversible, brain-penetrant, third-generation EGFR TKI exhibiting high selectivity for both activating and…
About Idelalisib Idelalisib is a medication used to treat certain blood cancers. Idelalisib acts as a phosphoinositide 3-kinase…
About Cobimetinib Cobimetinib is a MEK inhibitor. Cobimetinib is an anti-cancer medication used to treat melanoma and histiocytic neoplasms. Melanoma Indicated…
About Sacituzumab tirumotecan Sacituzumab tirumotecan, also known as sac-TMT, SKB264, or MK-2870, is an antibody-drug conjugate (ADC)…
About Odevixibat Odevixibat is a medication for the treatment of progressive familial intrahepatic cholestasis. Odevixibat is a reversible, potent,…
About Vorasidenib Vorasidenib is an oral, brain-penetrant, dual inhibitor of mutant isocitrate dehydrogenase 1 (IDH1) and…
Copyright © 2021-2022 LienTeh.net All rights reserved.
